期刊文献+

急性心肌梗死并发心源性休克的临床病例回顾 被引量:4

下载PDF
导出
摘要 目的分析急性心肌梗死(AMI)并心源性休克的临床特点。方法 100例AMI患者,根据病情分为休克组(20例)与非休克组(80例),对比两组患者的临床特点及抢救效果。结果两组患者年龄、性别、冠状动脉粥样硬化、心肌梗死病史及梗死部位无显著性差异(P>0.05)。与非休克组比较,休克组肌酸磷酸激酶和心肌肌钙蛋白I明显升高(P<O.05),采用溶栓治疗、冠状动脉造影、主动脉内气囊反搏者居多(P<0.05)。结论 AMI合并休克者病情凶险,及时判断、监测及处理,可明显改善患者的预后。 Objective To identify the clinical features and the outcome of patients with cardiogenic shock complicating acute myocardial infarction(AMI). Methods One hundred patients with AMI were included in this retrospective analysis. The characteristics,management, and outcome of patients with AMI were compared between patients with cardiogenic shock(group A, n=20)and without cardiogenic shock (group B,n=80). Results There was no difference in the age and other characteristics. The levels of troponin I were were higher than those"in group B (P〈0.05), in group A patients often underwent thrombolysis of urokinase; coronary angiography and intra--aortic balloon counterpulsation. Conclusion If cardiogenic shock complicating AMI is managed with rapid evaluation and prompt initiation of supportive measures and definitive therapy, outcomes can be improved.
作者 陈宝贵
出处 《当代医学》 2013年第29期46-47,共2页 Contemporary Medicine
关键词 急性心肌梗死 心源性休克 抢救 Acute myocardial infarction Cardiogenic shock Rescue
  • 相关文献

参考文献8

二级参考文献37

  • 1肖长华,杨希立,李健民,谭海斌,周昭仑.血浆脑钠素检测在急性心肌梗死患者的临床应用[J].岭南心血管病杂志,2004,10(3):192-192. 被引量:3
  • 2张志成,宋阳.cTnT、MYO和CK-MBmass对AMI的诊断价值[J].重庆医学,2004,33(8):1163-1165. 被引量:13
  • 3杨旭玲,裴晓冬.心肌肌钙蛋白T在急性冠脉综合征诊断中的意义[J].中国实验诊断学,2007,11(1):23-24. 被引量:7
  • 4王霄一,卢国元.B型钠尿肽评估血液透析患者干体重的临床意义[J].中国血液流变学杂志,2007,17(1):90-91. 被引量:9
  • 5Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretie peptide and brain natriuretie peptide. J Clin Invest, 1991,87 : 1402-1412.
  • 6Willems S, Hffmann B, Steven D, et al. Catheter ablation for atrial fibrillation: clinically established or still an experimental method? Herz ,2008,33:402-411.
  • 7Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atri fibrillation. Circulation ,2005,111 : 1100-1105.
  • 8Maggioni AP, Latini R, Carson PE, et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : results from the valsartan heart failure trial ( Val -HEFT). Am Heart J, 2005, 149:548-557.
  • 9Mak GS, DeMaria A, Clopton P, et al. Utility of B-natriuretic peptide in the evaluation of left ventrieular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J, 2004,148 : 895-902.
  • 10Beata Wozakowska-Kaplon. Effect of sinus rhythm on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardial, 2004,93 : 1555-1558.

共引文献53

同被引文献14

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部